Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background and Objective: Metabolomics has recently been applied in the field of oncology. In this study, we aimed to use metabolomics to explore biomarkers in peritoneal metastasis of gastric cancer. Methods: Peritoneal lavage fluid (PLF) of 65 gastric cancer patients and related clinical data were collected from the First Hospital of Jilin University. The metabolic components were identified by liquid chromatography-mass spectrometry (LC-MS). Total ion current (TIC) spectra, principal component analysis (PCA), and the Student’s t -test were used to identify differential metabolites in PLF. A support vector machine (SVM) was used to screen the differential metabolites in PLF with a weight of 100%. Cluster analysis was used to evaluate the similarity between samples. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic ability of the metabolites. Univariate and multivariate logistic regression analyses were used to identify potential risk factors for peritoneal metastasis of gastric cancer. Results: We found the differential levels of PLF metabolites by LC-MS, TIC spectra, PCA and the t -test. Cluster analysis showed the co-occurrence of metabolites in the peritoneal metastasis group (p< 0.05). ROC analysis showed the diagnostic ability of metabolites (p< 0.05). Univariate and multivariate logistic regression analyses showed the potential independent risk factors for peritoneal metastasis in gastric cancer patients (p< 0.05). Conclusion: Through the statistical analysis of metabolomics, we found that TG (54:2), G3P, α-aminobutyric acid, α-CEHC, dodecanol, glutamyl alanine, 3-methylalanine, sulfite, CL (63:4), PE-NMe (40:5), TG (53:4), retinol, 3-hydroxysterol, tetradecanoic acid, MG (21:0/0:0/0:0), tridecanoic acid, myristate glycine and octacosanoic acid may be biomarkers for peritoneal metastasis of gastric cancer. Keywords: gastric cancer, metabolomics, peritoneal metastasis, diagnosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Seventeen differential metabolites (sulfite, TG (54:2), TG (53:4), G3P, α-aminobutyric acid, α-CEHC, dodecanol, glutamyl alanine, 3-methyl alanine, 3-hydroxysteroid, CL (63:4), PE-NMe (40:5), retinol, MG (21:0/0:0/0:0), tetradecanoic acid, tridecanoic acid, octacosanoic acid and myristate glycine) were found with a weight of 100% using SVM.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These metabolites had potential predictive ability and independent risk factors for peritoneal metastasis of GC patients.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
METLIN—a metabolite mass spectral database
Smith, C. A., Maille, G. O., Want, E. J., Qin, C., Trauger, S. A., Brandon, T. R., Custodio, D. E., Abagyan, R., & Siuzdak, G. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000179845.53213.39 · Cited by 2,226
Ganapathy-Kanniappan, S. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1556578 · Cited by 216
Metabolomics in diagnosis and biomarker discovery of colorectal cancer
Zhang, A., Sun, H., Yan, G., Wang, P., Han, Y., & Wang, X. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.11.011 · Cited by 183
Applications of metabolomics to study cancer metabolism
Kaushik, A. K., & DeBerardinis, R. J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.009 · Cited by 179
Naeli, P., Pourhanifeh, M. H., Karimzadeh, M. R., Shabaninejad, Z., Movahedpour, A., Tarrahimofrad, H., Mirzaei, H. R., Bafrani, H. H., Savardashtaki, A., Mirzaei, H., et al. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102854 · Cited by 163
Gastric cancer: Metabolic and metabolomics perspectives (Review)
Xiao, S., & Zhou, L. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4000 · Cited by 158
Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers
Jamali, L., Tofigh, R., Tutunchi, S., Panahi, G., Borhani, F., Akhavan, S., Nourmohammadi, P., Ghaderian, S. M. H., Rasouli, M., & Mirzaei, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26850 · Cited by 154
Efficient Bacterial Inactivation by Transition Metal Catalyzed Auto-Oxidation of Sulfite
Chen, L., Tang, M., Chen, C., Chen, M., Luo, K., Xu, J., Zhou, D., & Wu, F. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b03705 · Cited by 148
Metabolomics in breast cancer: A decade in review
McCartney, A., Vignoli, A., Biganzoli, L., Love, R. R., Tenori, L., Luchinat, C., & Leo, A. D. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.04.012 · Cited by 127
Glucose metabolism in gastric cancer: The cutting-edge
Yuan, L., Yamashita, H., & Seto, Y. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i6.2046 · Cited by 127
Mirzaei, H., Khataminfar, S., Mohammadparast, S., Sales, S., Maftouh, M., Mohammadi, M., Simonian, M., Parizadeh, S., Hassanian, S., & Avan, A. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160818093854 · Cited by 121
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
Jiao, Y., Li, Y., Liu, S., Chen, Q., & Liu, Y. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s201675 · Cited by 103
Self-citationCirculating miR-21 as novel biomarker in gastric cancer: Diagnostic and prognostic biomarker
Simonian, M., Mosallayi, M., & Mirzaei, H. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.175428 · Cited by 103
Sirover, M. A. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9764-7 · Cited by 98
Applications of Metabolomics in Cancer Studies
Armitage, E. G., & Ciborowski, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-47656-8_9 · Cited by 97
Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
Fu, B., Yan, P., Zhang, S., Lü, Y., Li, P., Tang, W., Chen, S., Chen, S., Zhang, A., & Liu, W. (2018) · Disease Markers · doi:10.1155/2018/6437104 · Cited by 86
Self-citationPGM5: a novel diagnostic and prognostic biomarker for liver cancer
Jiao, Y., Li, Y., Jiang, P., Han, W., & Liu, Y. (2019) · PeerJ · doi:10.7717/peerj.7070 · Cited by 84
Self-citationPrognostic value of differentiation status in gastric cancer
Feng, F., Liu, J., Wang, F., Zheng, G., Wang, Q., Liu, S., Xu, G., Guo, M., Lian, X., & Zhang, H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4780-0 · Cited by 82
Metabolomics study of oral cancers
Chen, X., & Yu, D. (2019) · Metabolomics · doi:10.1007/s11306-019-1483-8 · Cited by 76
Jiao, Y., Fu, Z., Li, Y., Meng, L., & Liu, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s185459 · Cited by 70
Self-citationMarital status and survival in patients with gastric cancer
Jin, J., Wang, W., Faxiang, D., Long, Z., Cai, H., Liu, X., Zhou, Y., Huang, H., & Wang, Y. (2016) · Cancer Medicine · doi:10.1002/cam4.758 · Cited by 66
Jiao, Y., Li, Y., Lu, Z., & Liu, Y. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5315-x · Cited by 64
Self-citationCancer mortality predictions for 2019 in Latin America
Carioli, G., Bertuccio, P., Malvezzi, M., Rodríguez, T., Levi, F., Boffetta, P., Vecchia, C. L., & Negri, E. (2019) · International Journal of Cancer · doi:10.1002/ijc.32749 · Cited by 63
High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma
Li, Y., Jiao, Y., Fu, Z., Luo, Z., Su, J., & Li, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s196655 · Cited by 55
Self-citationThe Association of Digit Ratio (2D : 4D) with Cancer: A Systematic Review and Meta-Analysis
Bunevičius, A. (2018) · Disease Markers · doi:10.1155/2018/7698193 · Cited by 52
Predicting overall and major postoperative morbidity in gastric cancer patients
Coimbra, F. J. F., de Jesus, V. H. F., Franco, C. P., Calsavara, V. F., Ribeiro, H. S. C., Diniz, A. L., de Godoy, A. L., de Farias, I. C., Riechelmann, R. P., Begnami, M. D., et al. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25743 · Cited by 47
Zhang, H., Wang, L., Hou, Z., Ma, H., Mamtimin, B., Hasim, A., & Sheyhidin, I. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.060 · Cited by 45
Hou, L., Zhang, X., Jiao, Y., Li, Y., Zhao, Y., Guan, Y., & Liu, Z. (2019) · Medicine · doi:10.1097/md.0000000000015698 · Cited by 41
Self-citationOGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients
Jiao, Y., Li, Y., Fu, Z., Hou, L., Chen, Q., Cai, Y., Jiang, P., He, M., & Yang, Z. (2019) · Disease Markers · doi:10.1155/2019/9037131 · Cited by 37
Self-citationMunemoto, M., Mukaisho, K., Miyashita, T., Oyama, K., Haba, Y., Okamoto, K., Kinoshita, J., Ninomiya, I., Fushida, S., Taniura, N., et al. (2019) · Cancer Science · doi:10.1111/cas.14105 · Cited by 36
Low CYP24A1 mRNA expression and its role in prognosis of breast cancer
Cai, H., Jiao, Y., Li, Y., Yang, Z., He, M., & Liu, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-50214-z · Cited by 35
Self-citationWu, Y., Yao, Y., Shi, Y., Li, P., Xu, J., Chen, K., Xu, E., & Yang, J. J. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.06.007 · Cited by 34
Jiang, Z., Shen, H., Tang, B., Yu, Q., Ji, X., & Wang, L. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.032 · Cited by 32
Li, Y., Jiao, Y., Luo, Z., Li, Y., & Liu, Y. (2019) · Medicine · doi:10.1097/md.0000000000017703 · Cited by 28
Self-citationDiscovering Biomarkers in Bladder Cancer by Metabolomics
Zhang, W., Zhang, Z., Guo, Y., Wang, L., Mao, S., Zhang, J., Liu, M., & Yao, X. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0229 · Cited by 28
The effect of oxamflatin on the E-cadherin expression in gastric cancer cell line
Faghihloo, E., Araei, Y., Mohammadi, M., Mirzaei, H., Mohammadi, H., & Mokhtari‐Azad, T. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.52 · Cited by 27
Xu, L., Guo, T., Qu, X., Hu, X., Zhang, Y., Che, X., Song, H., Gong, J., Ma, R., Li, C., et al. (2018) · Cell Biology International · doi:10.1002/cbin.11023 · Cited by 26
Self-citationEnjoji, M., Kohjima, M., Ohtsu, K., Matsunaga, K., Murata, Y., Nakamuta, M., Imamura, K., Tanabe, H., Iwashita, A., Nagahama, T., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13216 · Cited by 25
Local resection of the stomach for gastric cancer
Kinami, S., Funaki, H., Fujita, H., Nakano, Y., Ueda, N., & Kosaka, T. (2016) · Surgery Today · doi:10.1007/s00595-016-1371-z · Cited by 22
Ramos‐Bueno, R. P., González‐Fernández, M. J., & Guil‐Guerrero, J. L. (2016) · Nutrition and Cancer · doi:10.1080/01635581.2016.1152382 · Cited by 22
Galata, C. L., Blank, S., Weiß, C., Ronellenfitsch, U., Reißfelder, C., & Hardt, J. (2019) · Cancers · doi:10.3390/cancers11121890 · Cited by 21
Xu, W., Cheng, Y., & Zhu, H. (2016) · Medicine · doi:10.1097/md.0000000000003700 · Cited by 21
Hu, D., Peng, F., Lin, X., Chen, G., Liang, B., Chen, Y., Li, C., Zhang, H., Fan, G., Xu, G., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4596-y · Cited by 20
Li, Y., Jiao, Y., Li, Y., & Liu, Y. (2019) · Disease Markers · doi:10.1155/2019/1569049 · Cited by 19
Self-citationKang, W., Zheng, Q., Lei, J., Chen, C., & Yu, C. (2018) · Disease Markers · doi:10.1155/2018/5340894 · Cited by 18
Tästensen, J., & Schönheit, P. (2018) · FEBS Letters · doi:10.1002/1873-3468.13037 · Cited by 15
Yue, X., He, J., Zhang, R., Xu, J., Zhou, Z., Zhang, R., Bi, N., Wang, Z., Sun, C., Wang, L., et al. (2018) · Journal of Chromatography A · doi:10.1016/j.chroma.2018.10.034 · Cited by 14
Dodurga, Y., Seçme, M., Güneş, C. E., Gündoğdu, G., Avcı, Ç. B., Bağcı, G., Küçükatay, V., & Şatıroğlu-Tufan, N. L. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.10.005 · Cited by 11
Zhang, W., Song, X.-H., Chen, X., Yang, K., Liu, K., Chen, Z., Zhou, Z., & Hu, J.-K. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1412-8 · Cited by 10
Oppermann, H., Birkemeyer, C., Meixensberger, J., & Gaunitz, F. (2019) · Cell Proliferation · doi:10.1111/cpr.12702 · Cited by 9
Ieni, A., Angelico, G., Barresi, V., Giuffrè, G., Arena, F., Caruso, R. A., & Tuccari, G. (2018) · Disease Markers · doi:10.1155/2018/1505428 · Cited by 7
Research works printed but not linked: 2
- Carioli, 2019, Int J Cancer
- Oppermann, 2019, Cell Prolif, e12702
Cited by
Huang, X., Pang, M.-J., Li, J.-Y., Chen, H., Sun, J., Song, Y., Ni, H.-J., Ye, S.-Y., Bai, S., Li, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36310-9 · Cited by 121
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“They divided the patients into two groups depending on the existence of peritoneal metastasis, serosal invasion, and CEA mRNA [59].”
BackgroundMicrobiota and metabolites alterations in proximal and distal gastric cancer patients
Yang, Y., Dai, D., Jin, W. Y., Huang, Y., Zhang, Y., Chen, Y., Wang, W., Wu, L., Chen, X., Zhang, J., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03650-x · Cited by 62
Self-citationMetabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring
Wang, W., Zhen, S., Yu, P., Wang, L., & Zhang, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1331215 · Cited by 45
Self-citationChen, X., Wu, Z., He, Y., Hao, Z., Wang, Q., Zhou, K., Zhou, W., Wang, P., Shan, F., Li, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202300961 · Cited by 36
Metadata
- Authors
- Pan, G., Ma, Y., Suo, J., Li, W., Zhang, Y., Qin, S., Jiao, Y., Zhang, S., Li, S., Kong, Y., Du, Y., Gao, S., & Wang, D.
- Affiliations
- First Hospital of Jilin University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Corresponding author
- Wang, Daguang
- ORCID
- Venue
- OncoTargets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2020-07
- Volume
- Volume 13
- Pages
- 7199-7211
- ISSN
- 1178-6930 (ISSN-L)
- PMC
- PMC7394602
- OpenAlex
- W3045423502
- Cited by
- 45
- References
- 52
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 21 · 2023: 6 · 2022: 8 · 2021: 3
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- OncoTargets and Therapy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Keywords
- gastric cancer, peritoneal carcinomatosis, biomarkers, peritoneal lavage fluid, differential metabolites, diagnostic biomarkers, risk factors, lipid metabolism, phospholipids, sphingolipids, amino acids, sulfite
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.